British American Tobacco - 2022 press releases

BAT celebrates inclusion in two leading global sustainability rankings

BAT’s sustainability leadership has been recognised by two leading global sustainability rankings, CDP and DJSI.

Reduced-risk* potential of Velo as cigarette alternative reinforced by innovative real-world study

New results from an innovative cross-sectional clinical study of Velo , BAT’s flagship modern oral nicotine pouch product, have been published today in Biomarkers Journal. In the study, consumers exclusively using Velo for over six months had significant favourable differences in several biomarkers of exposure and biomarkers of potential harm relevant to smoking-related diseases compared to the adults who smoked.

2022 Second Half Pre-Close Trading Update

Quote. Trading update - ahead of closed period commencing 1st January 2023.

BAT invests in Charlotte’s Web, a leading US producer of hemp extract wellness products

BAT Group (BAT) has today announced an investment in Charlotte’s Web Holdings, Inc. (Charlotte’s Web). Based in Colorado, USA and listed on the Toronto Stock Exchange, Charlotte’s Web is the #1 US brand in innovative hemp extract wellness products. Their product formats include tinctures, capsules, chews and topicals.

BAT joins call for action on biodiversity

BAT joins 300+ leading companies in signing Business for Nature’s call to protect and restore biodiversity, which complements its work to combat climate change.

Innovative new study to compare the health impact of Velo modern oral nicotine pouches to smoking

New study designed to identify differences in important early indicators associated with smoking-related disease between Velo users and smokers. Results will provide important new data and insights about Velo and its role in facilitating tobacco harm reduction.

BAT publishes ambitious roadmap to reach Net Zero by 2050

BAT has published its Low-Carbon Transition Plan, detailing the actions it will take to reach its climate targets. This includes halving absolute emissions across its value chain by 2030, from a 2020 baseline, and to be net zero across its value chain by 2050 at the latest .

BAT calls for collaboration to accelerate tobacco harm reduction

BAT’s Chief Growth Officer, Kingsley Wheaton, called for greater collaboration between the industry, governments, and intergovernmental organisations to accelerate tobacco harm reduction becoming the tobacco control policy of choice.

BAT announces Sanity Group investment

Following today’s announcement by one of Germany’s leading cannabis companies, Sanity Group GmbH (Sanity Group), BAT, via one of its wholly owned group companies, has acquired a non-controlling minority stake in the company.

New study reveals positive long-term impact of switching from cigarettes to glo™

The full results from a year-long study showed that smokers switching exclusively to glo, BAT’s flagship Tobacco Heating Product (THP), achieved significant and sustained improvements in several indicators of potential harm associated with early disease development compared to smokers who continued to smoke. This included lung disease, cancer, and cardiovascular disease (CVD).

BAT appoints Chief Sustainability Officer

BAT announces today that it has appointed Mike Nightingale as its first Chief Sustainability Officer to lead its sustainability and ESG agenda. Mike has been the Group Head of Investor Relations for the past 10 years. Prior to that, Mike held senior leadership positions in sustainability, regulation and marketing.

BAT’s ambitious 2030 decarbonisation target approved by SBTi

This month, the SBTi approved BAT’s target of a 50% reduction in Scope 1, 2 & 3 CO2e emissions by 2030 versus a 2020 baseline. SBTi determined that BAT’s 2030 target is in line with a 1.5oC-aligned trajectory and commended BAT for adopting the most ambitious designation available through the SBTi process.

Half-Year Report to 30 June 2022

Half-Year Report to 30 June 2022

BAT announces Board changes

Véronique Laury will join the Board of British American Tobacco p.l.c. as an independent Non-Executive Director and member of the Nominations and Audit Committees with effect from 19 September 2022.

BAT launches glo™ hyper X2: latest, state-of-the-art heated tobacco product

Today, BAT unveiled glo™ hyper X2 in Tokyo, Japan, the latest innovation from glo™, BAT’s fast-growing global heated tobacco brand. The product’s innovative new ‘barrel styling’ design is shaped by consumer insights, offering new, innovative, user-friendly features.

2022 First Half Pre-Close Trading Update

Trading update - ahead of closed period commencing 26 June 2022.

BAT conducts first real-world study assessing the impact of Vuse on indicators for several smoking-related diseases

BAT has conducted a first-of-its-kind study of Vuse designed to assess and provide insights into the real-world health impact of vaping. The study compares biomarker measures from Vuse consumers who have been using the product for over six months with the results from smokers, former smokers and never smokers.

Vuse Vibe and Vuse Ciro receive US FDA Marketing Authorization

Today, BAT’s U.S. indirect subsidiary, R. J. Reynolds Vapor Company, received Marketing Authorization from the U.S. Food and Drug Administration (FDA) for certain Vuse Ciro and Vuse Vibe products that will allow them to remain on the market in the United States. This news builds on the prior Marketing Authorizations granted by FDA in October 2021 for Vuse Solo products in original flavour.

BAT notes FDA announcement on product standard for menthol cigarettes

2022 AGM: Chairman's address

2022 AGM: Chairman's address

BAT Announces Management Board Change

Marina Bellini, Director, Digital and Information will step down from the Management Board on 31 March 2022 and will leave BAT on 31 July 2022 to pursue new opportunities. Javed Iqbal, currently Area Director, Middle East South Asia, will succeed Marina as Director, Digital and Information and will be appointed to the Management Board effective 1 April 2022.

Russia business update and revised guidance

The context is highly complex, exceptionally fast-moving and volatile. We have concluded that BAT’s ownership of the business in Russia is no longer sustainable in the current environment.

BAT statement on Ukraine/Russia

A BAT spokesperson said: “We are deeply concerned about the conflict in Ukraine.The safety and wellbeing of our people there and across the region is our first priority. We have full local establishments of 1,000 people in Ukraine and 2,500 in Russia. Our thoughts are with them all at this incredibly difficult time.

BAT to present at the 2022 Consumer Analyst Group of New York (CAGNY) conference

BAT’s Chief Executive, Jack Bowles, Finance and Transformation Director, Tadeu Marroco, and Chief Marketing Officer, Kingsley Wheaton, will present tomorrow at the 2022 Consumer Analyst Group of New York (CAGNY) Virtual Conference.

BAT appoints new Chief Medical Officer

BAT has appointed Dr. Senthil Vel, MBBS MBA MFPM FFPM, as its new Chief Medical Officer. Dr Vel will play a central role in BAT’s extensive research and development programmes, which supports the company’s commitment to reducing the health impact of its business by offering consumers a range of alternative reduced risk*† tobacco and nicotine products

Preliminary announcement - year ended 31 December 2021

2021 – A PIVOTAL YEAR DELIVERED; BUYBACK ANNOUNCED

British American Tobacco announces Board changes

Krishnan “Kandy” Anand will join the Board of British American Tobacco p.l.c. (BAT) as an independent Non-Executive Director and member of the Nominations and Remuneration Committees with effect from 14 February 2022.

Share buyback programme

British American Tobacco p.l.c. (the "Company") has today announced a programme to buyback up to £2 billion of BAT ordinary shares (the “Programme”), alongside its Full Year 2021 results. The Programme will commence on 14 February 2022 and will end no later than 31 December 2022.

BAT recognised as Global Top Employer for fifth consecutive year

BAT is proud to announce that it has been named a Global Top Employer for the fifth year running by the Top Employers Institute.BAT is one of just 11 companies to receive Global Top Employer certification for 2022, which is based on an extensive review of employer practices across six HR domains and 20 topics, including People Strategy, Work Environment, Talent Acquisition, Learning, Well-being, Diversity & Inclusion and more.

BAT launches virtual R&D Visitor Experience, showcasing the world-class science behind next generation reduced-risk^*† nicotine products

BAT has created a virtual R&D Visitor Experience, an online tour of its global Research & Development hub in Southampton, UK, that allows people to explore its cutting-edge science and innovation.

BAT creates biotech company KBio to accelerate development of existing plant-based technology

BAT today announced the launch of KBio Holdings Limited (KBio) to accelerate the research, development and production of novel treatments.